Rumoured Media Hype On Lapatinib

Матеріал з HistoryPedia
Версія від 08:14, 9 квітня 2017, створена Salebabies1 (обговореннявнесок) (Створена сторінка: In hospitalized controls, we observed a trend of decreasing microbial diversity with increasing proportions of human DNA (r = ?0.50, P = 0.003 by Spearman's ran...)

(різн.) ← Попередня версія • Поточна версія (різн.) • Новіша версія → (різн.)
Перейти до: навігація, пошук

In hospitalized controls, we observed a trend of decreasing microbial diversity with increasing proportions of human DNA (r = ?0.50, P = 0.003 by Spearman's rank correlation test; Figure 2). This trend was not observed in CDI cases (r = ?0.14, Lapatinib P = 0.6). Patients with incipient CDI exhibited overall low levels of microbial diversity, a feature that is already associated with CDI susceptibility [26]. Nonetheless, intestinal inflammation could be the common link between increased epithelial cell shedding and reduced microbial diversity. Figure 2 Intestinal microbiota diversity in hospitalized cases and controls as a function of host DNA abundance. Each patient group was divided into three subgroups with low (Crenolanib cost in size from 0.5 to more than 9 Mb and contain between 1 and 15 copies of the 16S rRNA gene [27, 28], so the naive expectation for pure bacterial samples would be to observe approximately one 16S rDNA read per Mb of sequence data. Within our population of 54 hospitalized patients and two healthy subjects, the frequency of 16S rDNA motifs ranged from 0.1 to 0.7 occurrences per Mb of total sequence data after accounting for host DNA. In a comparable analysis of a variety of individually sequenced bacterial species (Listeria monocytogenes, Vibrio fluvialis, Salmonella enterica, and Campylobacter jejuni) with genome sizes ranging from 1.8 to 6.7?Mb and 16S rDNA copy numbers ranging from 1 to 8, rDNA motifs were observed at a frequency of 1 to 3 occurrences per Mb. Therefore, 16S rDNA motif recovery rates differed by an order of magnitude between purified bacterial cultures and fecal microbiome samples. Whereas fecal DNA samples have been considered to be predominantly of bacterial origin, our results imply that other sources of DNA that are not of bacterial or human origin (e.g., food, fungi, protozoa, bacteriophages, and other viruses) account for a substantial fraction of the fecal microbiome and likely play a role in the interplay between the microbial community and the host. Nielsen et al. have also recognized that the microbiome is composed of a wide variety of microbes and approaches assessing the full genetic diversity are Liothyronine Sodium needed [29]. Even with the paucity of robust tools to identify these other sources of DNA, the use of methods that survey the whole community rather than focusing only on bacteria, such as WGS sequencing, offers a starting point for taking a census of the entire microbiome. We also examined whether specific bacterial genera are associated with fecal excretion of human DNA in hospitalized patients. In the incipient CDI group, Prevotella was more abundant in patients with low levels of host DNA. This genus is a common member of the fecal microbiota in adults [30].